Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
Canadian Medical Association Journal2008Vol. 180(1), pp. 32–39
Citations Over TimeTop 1% of 2008 papers
Abstract
Long-term thiazolidinedione use doubles the risk of fractures among women with type 2 diabetes, without a significant increase in risk of fractures among men with type 2 diabetes.
Related Papers
- → Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease(2011)120 cited
- → Clinical trials with thiazolidinediones in subjects with Type 2 diabetes – is pioglitazone any different from rosiglitazone?(2008)28 cited
- → Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone(2005)12 cited
- The comparison study of pioglitazone and rosiglitazone on type 2 diabetes with hyperlipemia(2009)
- → Cardiovascular safety of rosiglitazone and pioglitazone(2015)